Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget
This article was originally published in PharmAsia News
PERTH, Australia - The Australian federal 2009-2010 budget announced May 12, delivered a mixed bag to pharmaceutical and biotech companies, with biotech companies praising the R&D tax credit and Big Pharma critical of cuts to the Pharmaceutical Benefits Scheme
You may also be interested in...
PERTH, Australia - A new report by Access Economics says that spending on Australia's Pharmaceutical Benefits Scheme will not spiral out of control as previously predicted by the Liberal Howard government, Medicines Australia announced April 3
PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry
PERTH, Australia - Investment in Australia's biotech sector plummeted to AU$183 million in 2008, down from AU$ 943 million in 2007, AusBiotech reported